A Randomized Open-Label Clinical Trial of Lipid-Lowering Therapy in Psoriasis to Reduce Vascular Endothelial Inflammation

J Invest Dermatol. 2022 Jun;142(6):1749-1752.e4. doi: 10.1016/j.jid.2021.07.190. Epub 2021 Nov 19.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
  • Inflammation / drug therapy
  • Lipids
  • Psoriasis* / drug therapy
  • Treatment Outcome

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipids